Section 4: Clinical Pharmacy Services 2021
DOI: 10.1136/ejhpharm-2021-eahpconf.192
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-360 Risk of malnutrition in patients with COVID-19 disease who receive oral nutritional supplements

Abstract: cohort (p=0.273). Patients were classified into three risk categories (high, medium and low) and had the following rates of risk: 11.1% (0-6 points), 20.0% (8-13 points) and 39.5% (>13 points). Findings were similar in the validation cohort. The optimal cutoff point in the model was 9, having a sensitive of 67.09%, a specificity of 69.06%, a positive predictive value of 36.78%, and a negative predictive value of 87.61%. Conclusion and relevance This score could be used by clinicians from the ED to identify tho… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles